10.1016/s2666-5247(22)00301-9 - Evaluation of Nanopore sequencing for...

This document has been corrected

Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis

10.1016/s2666-5247(22)00301-9

Published Online: 2023-02-?

Journal: The Lancet Microbe•Publisher: Elsevier BV

Authors: Anastasia Koch•Anzaan Dippenaar•Derrick Crook•Helen Cox•Marie Sylvianne Rabodoarivelo•Melanie Grobbelaar•Michael B Hall•Niaina Rakotosamimanana•Robin Warren•Sebastien Gagneux•Simon Grandjean Lapierre•Sophie George•Tim Peto•Timothy M Walker•Zamin Iqbal

This document has been corrected

Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis

10.1016/s2666-5247(22)00301-9

Published Online: 2023-02-?

Journal: The Lancet Microbe

NOW

2023-02-01•Erratum

Correction to Lancet Microbe 2022; published online Dec 19, 2022. https://doi.org/10.1016/S2666-5247(22)00301-9

10.1016/s2666-5247(22)00381-0

* information provided by CrossRef

2023-02-01•Erratum

10.1016/s2666-5247(22)00381-0

* information provided by CrossRef

2023-02-?•Published

2023-02-01•Erratum

Correction to Lancet Microbe 2022; published online Dec 19, 2022. https://doi.org/10.1016/S2666-5247(22)00301-9

10.1016/s2666-5247(22)00381-0

* information provided by CrossRef

This document has been corrected

Evaluation of Nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis

10.1016/s2666-5247(22)00301-9

Published Online: 2023-02-?

Journal: The Lancet Microbe•Publisher: Elsevier BV